OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KANE60

Kansai Nerolac Paints Ltd

Commodity ChemicalsVerified

Kansai Nerolac Paints Ltd maintains a strong liquidity position, with a current ratio of 3.69, indicating the company can cover its short-term liabilities more than three times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints in the near term. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its debt-to-equity ratio of 0.05, indicating a relatively low leverage position. In terms of profitability, Kansai Nerolac Paints Ltd demonstrates a return on equity (ROE) of 17.79% and a return on assets (ROA) of 13.91%, both of which are strong indicators of efficient capital utilization and asset management. These metrics are well above the industry median for Commodity Chemicals, suggesting the company is outperforming its peers in generating returns for shareholders and utilizing its asset base effectively. The company's revenue is primarily concentrated in the domestic market, with a significant portion derived from the construction and industrial sectors. While the company has a presence in international markets, its revenue concentration remains heavily weighted toward India, exposing it to local economic and regulatory risks. The company's geographic exposure is not diversified, which could limit its ability to offset domestic downturns with international growth. Kansai Nerolac Paints Ltd is projected to experience moderate growth in the current fiscal year, with revenue expected to increase by a low single-digit percentage. The company's capital expenditure of -3.26 billion INR indicates a reduction in investment in new projects or infrastructure, which may signal a more conservative approach to growth in the near term. This aligns with the company's current focus on maintaining liquidity and managing debt levels. The company's risk profile is characterized by a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. The company's risk assessment indicates a low probability of near-term dilution, with no immediate pressure from share issuance or convertible instruments. However, the company's negative net cash position and the presence of long-term debt of 2.96 billion INR suggest that it may need to raise additional capital in the future, which could introduce dilution risk. Recent events, including analyst estimates and price targets, indicate a generally positive outlook for the company. The mean price target of 248.50 INR and the median price target of 249.00 INR suggest that analysts expect the stock to appreciate in value over the next 12 months. The company has received a mix of strong-buy, buy, and hold recommendations, with a mean recommendation score of 2.38, indicating a cautiously optimistic sentiment among analysts.

30-day price · KANE+32.64 (+17.6%)
Low$184.50High$224.45Close$217.94As of22 May, 00:00 UTC
Profile
CompanyKansai Nerolac Paints Ltd
TickerKANE.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Kansai Nerolac Paints Ltd is a manufacturer and distributor of paints, coatings, and related products, primarily serving the construction, automotive, and industrial sectors.

Classification. Kansai Nerolac Paints Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Kansai Nerolac Paints Ltd maintains a strong liquidity position, with a current ratio of 3.69, indicating the company can cover its short-term liabilities more than three times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints in the near term. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its debt-to-equity ratio of 0.05, indicating a relatively low leverage position. In terms of profitability, Kansai Nerolac Paints Ltd demonstrates a return on equity (ROE) of 17.79% and a return on assets (ROA) of 13.91%, both of which are strong indicators of efficient capital utilization and asset management. These metrics are well above the industry median for Commodity Chemicals, suggesting the company is outperforming its peers in generating returns for shareholders and utilizing its asset base effectively. The company's revenue is primarily concentrated in the domestic market, with a significant portion derived from the construction and industrial sectors. While the company has a presence in international markets, its revenue concentration remains heavily weighted toward India, exposing it to local economic and regulatory risks. The company's geographic exposure is not diversified, which could limit its ability to offset domestic downturns with international growth. Kansai Nerolac Paints Ltd is projected to experience moderate growth in the current fiscal year, with revenue expected to increase by a low single-digit percentage. The company's capital expenditure of -3.26 billion INR indicates a reduction in investment in new projects or infrastructure, which may signal a more conservative approach to growth in the near term. This aligns with the company's current focus on maintaining liquidity and managing debt levels. The company's risk profile is characterized by a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. The company's risk assessment indicates a low probability of near-term dilution, with no immediate pressure from share issuance or convertible instruments. However, the company's negative net cash position and the presence of long-term debt of 2.96 billion INR suggest that it may need to raise additional capital in the future, which could introduce dilution risk. Recent events, including analyst estimates and price targets, indicate a generally positive outlook for the company. The mean price target of 248.50 INR and the median price target of 249.00 INR suggest that analysts expect the stock to appreciate in value over the next 12 months. The company has received a mix of strong-buy, buy, and hold recommendations, with a mean recommendation score of 2.38, indicating a cautiously optimistic sentiment among analysts.
Key takeaways
  • Kansai Nerolac Paints Ltd has a strong liquidity position with a current ratio of 3.69, but its net cash is negative after subtracting total debt.
  • The company's ROE of 17.79% and ROA of 13.91% indicate strong profitability and efficient asset utilization.
  • Revenue is heavily concentrated in the domestic market, exposing the company to local economic and regulatory risks.
  • The company is projected to experience moderate growth in the current fiscal year, with a conservative approach to capital expenditure.
  • Analysts have a cautiously optimistic outlook, with a mean price target of 248.50 INR and a mean recommendation score of 2.38.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$78.23B
Gross profit$26.20B
Operating income$13.70B
Net income$11.43B
R&D
SG&A
D&A
SBC
Operating cash flow$6.72B
CapEx-$3.26B
Free cash flow$6.82B
Total assets$82.17B
Total liabilities$17.94B
Total equity$64.23B
Cash & equivalents$940.0M
Long-term debt$2.96B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$64.23B
Net cash-$2.02B
Current ratio3.7
Debt/Equity0.1
ROA13.9%
ROE17.8%
Cash conversion59.0%
CapEx/Revenue-4.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricKANEActivity
Op margin17.5%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin14.6%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin33.5%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-4.2%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity5.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Observations
IR observations
Mean price target248.50 INR
Median price target249.00 INR
High price target302.00 INR
Low price target191.00 INR
Mean recommendation2.38 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count5.00
Hold count4.00
Sell count3.00
Strong-sell count0.00
Mean EPS estimate8.80 INR
Last actual EPS8.05 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-24 14:35 UTC#cf56c31a
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 07:19 UTCJob: 3e69cdb1